Sign In  |  Register  |  About Walnut Creek Guide  |  Contact Us

Walnut Creek, CA
September 01, 2020 1:43pm
7-Day Forecast | Traffic

  • Search Hotels in Walnut Creek Guide

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 Next >
10 Health Care Stocks Whale Activity In Today's Session
Tickers AMGN CI DOCS HIMS
Tags AMGN HIMS IONS
From Benzinga
A Glimpse Into The Expert Outlook On Ionis Pharmaceuticals Through 5 Analysts
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
Where Ionis Pharmaceuticals Stands With Analysts
Tickers IONS
Tags Market News Analyst Ratings IONS
From Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Tickers ADPT ARKG ARKK CDNA
Tags Cathie Wood IONS ADPT
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (13 Ratings)
Tickers IONS
Tags Analyst Ratings Market News Benzinga
From Benzinga
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Tickers APLD DBX EXTR HPE
Tags HPE RBRK Markets
From Benzinga
Why Oracle Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Tickers AMZN ASNS AVO CNET
Tags TVGN Pre/Market Outlook IONS
From Benzinga
What 14 Analyst Ratings Have To Say About Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR IONS Benzinga
From Benzinga
12 Analysts Have This To Say About Ionis Pharmaceuticals
Tickers IONS
Tags IONS BZI/AAR Benzinga
From Benzinga
Ionis' Rare Development Disorder Drug Candidate 'Could Be Differentiated' From Peer Ultragenyx: Analyst
Tickers ALNY AZN BIIB IONS
Tags Expert Ideas Analyst Color Stories That Matter
From Benzinga
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News Benzinga
From Benzinga
Assessing Ionis Pharmaceuticals: Insights From 6 Financial Analysts
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
RXO, Alnylam Pharmaceuticals And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Tickers ALNY ALT ARGX CLOV
Tags PHAR Markets IONS
From Benzinga
Deep Dive Into Ionis Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Tickers IONS
Tags Analyst Ratings Market News Benzinga
From Benzinga
Ionis Pharmaceuticals Reveals Late-Stage Donidalorsen Data, Analyst Says Results Show Competitive Hereditary Angioedema Profile
Tickers IONS NEWS
Tags Health Care Equities Biotech
From Benzinga
Europe Approves Biogen's Tofersen For Adult Patients With Rare Type Of Neurodegenerative Disorder
Tickers BIIB IONS NEWS
Tags Briefs News Biotech
From Benzinga
Tale Of Two Ionis-Partnered Neurology-Focused Early Stage Assets-Biogen Discontinues One, Decides Not To Exercise Licensing Option For Another
Tickers BIIB IONS NEWS
Tags Stories That Matter News why it's moving
From Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in May 2024
Tickers BIIB IONS SNY
Tags SNY BIIB IONS
From InvestorPlace
The Analyst Landscape: 8 Takes On Ionis Pharmaceuticals
Tickers IONS
Tags Analyst Ratings Market News IONS
From Benzinga
IONS Stock Earnings: Ionis Pharmaceuticals Beats EPS, Misses Revenue for Q1 2024
Tickers IONS
Tags NASDAQ:IONS Market News IONS
From InvestorPlace
The Latest Analyst Ratings For Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
Genetic Medicines Focused-Ionis Pharmaceuticals' Fatty Liver Candidate Lowers Excess Liver Fat, Midstage Study Data Shows
Tickers IONS NEWS
Tags Health Care Large Cap Biotech
From Benzinga
Cracking The Code: Understanding Analyst Reviews For Ionis Pharmaceuticals
Tickers IONS
Tags BZI/AAR IONS Benzinga
From Benzinga
Earnings Scheduled For February 21, 2024
Tickers ACVA ADI AGI AGR
Tags GIL GNK CHDN
From Benzinga
JP Morgan Maintains Neutral Rating for Ionis Pharmaceuticals: Here's What You Need To Know
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR/UPDATE
From Benzinga
Biogen Gives Up On Aduhelm Efforts After Two Years Of Controversial FDA Accelerated Approval For Alzheimer's, Shifts Focus On Newer Medicines
Tickers BIIB IONS NEWS
Tags Market News Stories That Matter pharmaceuticals
From Benzinga
Rare Disease Focused Ionis Pharmaceuticals Gears Up for FDA Submission After Donidalorsen Outperforms Placebo In Swollen Vessels Study
Tickers IONS NEWS
Tags Briefs News General
From Benzinga
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
Tickers IONS
Tags Analyst Ratings Market News IONS
From Benzinga
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
Tickers ALNY ARM CPRI IONS
Tags Market News MRK Benzinga
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Tickers ABBV ALNY CVS GILD
Tags ABBV MRNA Benzinga
From Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 WalnutCreekGuide.com & California Media Partners, LLC. All rights reserved.